Ozan Pamir
Director of Finance/CFO chez 180 LIFE SCIENCES CORP.
Fortune : 1 102 $ au 31/03/2024
Profil
Ozan Pamir is currently the Chief Financial Officer & Secretary at 180 Life Sciences Corp.
He previously worked as the Chief Financial Officer & Director at Unify Pharmaceuticals Corp.
from 2019 to 2021, and as the Chief Financial Officer at Global Gaming Technologies Corp.
in 2019.
Prior to that, he served as the Vice President-Investment Banking at Echelon Wealth Partners, Inc. from 2014 to 2018.
Mr. Pamir's education includes an undergraduate degree from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
180 LIFE SCIENCES CORP.
0,06% | 18/12/2023 | 473 ( 0,06% ) | 1 102 $ | 31/03/2024 |
Postes actifs de Ozan Pamir
| Sociétés | Poste | Début |
|---|---|---|
| 180 LIFE SCIENCES CORP. | Director of Finance/CFO | 01/10/2018 |
Anciens postes connus de Ozan Pamir
| Sociétés | Poste | Fin |
|---|---|---|
Unify Pharmaceuticals Corp.
 Unify Pharmaceuticals Corp. BiotechnologyHealth Technology Unify Pharmaceuticals Corp. is an American biotech company that focuses on developing drugs for neurodegenerative diseases. The private company is based in Tennessee. | Director of Finance/CFO | 01/07/2021 |
Enosi Life Sciences Corp.
 Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Director of Finance/CFO | - |
| GLOBAL GAMING TECHNOLOGIES CORP. | Director of Finance/CFO | 15/08/2019 |
Echelon Wealth Partners, Inc.
 Echelon Wealth Partners, Inc. Investment Banks/BrokersFinance Echelon Wealth Partners, Inc. (Echelon) is the wealth management and capital markets subsidiary of Echelon Wealth Holdings, Inc. in Canada. The firm was founded in 2010 by Robert Furse and David Cusson. Headquartered in Toronto, Echelon provides creative solutions and execution to their institutional and retail clients. | Corporate Officer/Principal | 01/10/2018 |
Formation de Ozan Pamir
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
| 180 LIFE SCIENCES CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Echelon Wealth Partners, Inc.
Echelon Wealth Partners, Inc. Investment Banks/BrokersFinance Echelon Wealth Partners, Inc. (Echelon) is the wealth management and capital markets subsidiary of Echelon Wealth Holdings, Inc. in Canada. The firm was founded in 2010 by Robert Furse and David Cusson. Headquartered in Toronto, Echelon provides creative solutions and execution to their institutional and retail clients. | Finance |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Health Technology |
Unify Pharmaceuticals Corp.
Unify Pharmaceuticals Corp. BiotechnologyHealth Technology Unify Pharmaceuticals Corp. is an American biotech company that focuses on developing drugs for neurodegenerative diseases. The private company is based in Tennessee. | Health Technology |
